Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2010
10/07/2010CA2757178A1 Mutants of activation-induced cytidine deaminase (aid) and methods of use
10/07/2010CA2756988A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/07/2010CA2756938A1 Isolation of human umbilical cord blood-derived mesenchymal stem cells
10/07/2010CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010CA2755887A1 Method for inducing cell death in pluripotent stem cells and differentiated cells other than cardiac myocytes
10/07/2010CA2749512A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and use thereof
10/06/2010EP2236614A2 Brain endothelial cell expression patterns
10/06/2010EP2236605A1 Human anti- 9 integrin antibody
10/06/2010EP2236602A1 Lipolytic enzyme variants
10/06/2010EP2236599A1 Method for isolation of inner cell mass and method of preparation of embryonic stem cell lines using inner cell mass isolated by the same
10/06/2010EP2236515A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa
10/06/2010EP2236514A1 Artificial peptide and use thereof
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2235173A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
10/06/2010EP2235162A1 Method of producing a population of cells
10/06/2010EP2235161A1 Small molecules for neuronal differentiation of embryonic stem cells
10/06/2010EP2235160A1 Protein-free gamete and embryo handling and culture media products
10/06/2010EP2235051A2 Glycosyltransferases, polynucleotides encoding these and methods of use
10/06/2010EP1594958B1 Activation and expansion of t cells
10/06/2010EP1551449B1 Reagents and methods for engaging unique clonotypic lymphocyte receptors
10/06/2010EP1456650B1 Gfats as modifiers of the p53 pathway and methods of use
10/06/2010EP1352077B1 Materials and methods relating to protein aggregation in neurodegenerative disease
10/06/2010EP1254369B1 Cells for drug discovery
10/06/2010EP1100880B1 Urate oxidase
10/06/2010EP0873363B1 High affinity human antibodies to tumor antigens
10/06/2010CN1922306B Systems and methods for clonal expression in plants
10/06/2010CN1745626B Modified cell line of male mammal, its production and use thereof
10/06/2010CN101855350A Method of nuclear reprogramming
10/06/2010CN101855349A West nile virus vaccine, and method for production thereof
10/06/2010CN101855347A Novel ATP:citrate lyase genes
10/06/2010CN101855341A Method for creating perfusable microvessel systems
10/06/2010CN101855340A Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of cells
10/06/2010CN101855339A Human cancer stem cells
10/06/2010CN101855338A Wnt pathway stimulation in reprogramming somatic cells
10/06/2010CN101855337A Soft gel systems in modulating stem cell development
10/06/2010CN101854949A Methods and compositions for modulating t cells
10/06/2010CN101853495A Cell separation method based on morphology
10/06/2010CN101851639A Locating and integrating carrier for human gdnf gene on cow beta-casein locus and application thereof
10/06/2010CN101851638A Cow fetus fibroblast cell containing Iprl macrophage metamerism expression vector
10/06/2010CN101851636A Recombinant influenza viruses for vaccines and gene therapy
10/06/2010CN101851607A Canine-SLAM/Vero cell line and constructing method
10/06/2010CN101851606A Cumulus oophorus-oocyte compound cutting filter method
10/06/2010CN101851605A Selective medium of liver stem cells, method for selectively separating and amplifying liver stem cells as well as medicinal composition for treating diabetes
10/06/2010CN101851604A Method for producing human albumin
10/06/2010CN101851603A Mycoplasma clearing reagent and application thereof
10/06/2010CN101851601A Culture medium for inducing somatic embryos from garlic embryonic suspension culture system
10/06/2010CN101851290A Preparation and production technology of humanization NOGO-A resisting monoclonal antibody
10/06/2010CN101851289A Humanized antibody of H5 subtype avian influenza virus hemagglutinin and application thereof
10/06/2010CN101851286A Mammalian cytokine: interleukin-B30 and related reagents
10/06/2010CN101851283A Malus xiaojinensis MxCS protein and coded gene and application thereof
10/06/2010CN101851282A Protein MtCBF4 associated with stress tolerance of plants, encoding gene and application thereof
10/06/2010CN101851279A Pseudomonas aeruginosa antigens
10/06/2010CN101851278A B cell activating factor antagonist as well as preparation method and application thereof
10/06/2010CN101334356B Gas sensors
10/06/2010CN101265295B Tocopherol synthesis correlated albumen, coding gene and application thereof
10/06/2010CN101147466B Minitype ginger seedling tissue culture fast propagating culture medium and tissue culture fast propagating method
10/06/2010CN101126096B Firefly luciferase gene and application thereof
10/06/2010CN101113163B Hla-a24-restricted cancer antigen peptides
10/06/2010CN101066477B Biological artificial blood vessel capable of in vivo capturing endothelial ancestral cell
10/05/2010US7807904 Plants and seeds of hybrid corn variety CH744092
10/05/2010US7807903 Plants and seeds of hybrid corn variety CH440457
10/05/2010US7807902 Plants and seeds of corn variety CV201191
10/05/2010US7807901 Plants and seeds of hybrid corn variety CH467836
10/05/2010US7807900 Plants and seeds of hybrid corn variety CH511197
10/05/2010US7807899 Plants and seeds of hybrid corn variety CH720554
10/05/2010US7807898 Plants and seeds of hybrid corn variety CH020448
10/05/2010US7807897 Plants and seeds of hybrid corn variety CH035643
10/05/2010US7807887 Plants and seeds of corn variety CV427441
10/05/2010US7807879 Stimulating root growth via introducing cytokinin oxidase protein sequences; point mutations
10/05/2010US7807878 Transgenic trees exhibiting increased growth, biomass production and xylem fibre length, and methods for their production
10/05/2010US7807877 Genetic sequences having methyltransferase activity and uses therefor
10/05/2010US7807868 Mobilization of viral genomes from T-DNA using site-specific recombination systems
10/05/2010US7807867 Expression vector comprising nucleotide sequences coding plant growth regulator; enhancing cell division and bud formation; overcoming dormancy of axillary buds; preventing aging and promoting enlargement of fruit
10/05/2010US7807865 Transgene assay using stable agrobacterium rhizogenes transformation
10/05/2010US7807863 Transgenic bovine having reduced prion protein activity and uses thereof
10/05/2010US7807849 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
10/05/2010US7807812 Actin regulatory elements for use in plants
10/05/2010US7807811 Actin regulatory elements for use in plants
10/05/2010US7807805 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
10/05/2010US7807801 Method of inhibition of flavivirus to prevent and cure viral diseases by administering nucleotides
10/05/2010US7807796 ULBP antibodies
10/05/2010US7807795 Antibodies to osteoprotegerin binding proteins
10/05/2010US7807787 NELL-1 (Nel-like molecule-1) polypeptide for use in induction and treatment of bone formation and disorders
10/05/2010US7807784 Immunosuppression of lymphocytes by introducing a cDNA molecule encoding mutant LIGHT into the tumor, and expressing the cDNA molecule; antitumor agents, tumor antigens; drug screening
10/05/2010US7807778 Cysteine-containing peptide tag for site-specific conjugation of proteins
10/05/2010US7807647 administering an antigene oligonucleotide that hybridizes under physiological conditions to the promoter region of a bcl-2 gene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers; docetaxel
10/05/2010US7807641 Methods and reagents for treating glucose metabolic disorders
10/05/2010US7807626 inhibiting prostate cancer cell proliferation and causing prostate cancer cell apoptosis; administering a biodrug with amino acid sequence; anticarcinogenic agents
10/05/2010US7807464 Propagating hematopoietic stem cells (HSCs) in nutrient broth comprising angiopoietin-like protein and stem cell factor (SCF); tissue engineering and disase therapy
10/05/2010US7807462 Method for producing a functional neuron
10/05/2010US7807461 Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same
10/05/2010US7807460 Plasmid regulated by heat-shock sigma factor for use as gene transfer tool in genetic engineering; improved/enhanced exogenous transcription
10/05/2010US7807459 EphA4-positive human adult pancreatic endocrine progenitor cells
10/05/2010US7807458 Nutrient broth comprising multipotent cells for use in propagation of mesodermal, neuroectodermal, and endodermal cells; tissue engineering
10/05/2010US7807457 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars
10/05/2010US7807453 Device for cell culture on deformable surfaces
10/05/2010US7807442 PUFA polyketide synthase systems and uses thereof
10/05/2010US7807441 Nucleotide sequences which code protein that induces cytotoxic T-lymphocyte immunity against weak selfproteins; antitumor agents
10/05/2010US7807434 Detergent composition comprising enhanced glucanase for use in textile treatment and enhancing cleaning performance
10/05/2010US7807430 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening